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Argonaute proteins are essential components of the molecular machinery that drives RNA silencing. In Drosophila,
different members of the Argonaute family of proteins have been assigned to distinct RNA silencing pathways. While
Ago1 is required for microRNA function, Ago2 is a crucial component of the RNA-induced silencing complex in siRNA-
triggered RNA interference. Drosophila Ago2 contains an unusual amino-terminus with two types of imperfect
glutamine-rich repeats (GRRs) of unknown function. Here we show that the GRRs of Ago2 are essential for the normal
function of the protein. Alleles with reduced numbers of GRRs cause specific disruptions in two morphogenetic
processes associated with the midblastula transition: membrane growth and microtubule-based organelle transport.
These defects do not appear to result from disruption of siRNA-dependent processes but rather suggest an
interference of the mutant Ago2 proteins in an Ago1-dependent pathway. Using loss-of-function alleles, we further
demonstrate that Ago1 and Ago2 act in a partially redundant manner to control the expression of the segment-polarity
gene wingless in the early embryo. Our findings argue against a strict separation of Ago1 and Ago2 functions and
suggest that these proteins act in concert to control key steps of the midblastula transition and of segmental
patterning.
Citation: Meyer WJ, Schreiber S, Guo Y, Volkmann T, Welte MA, et al. (2006) Overlapping functions of Argonaute proteins in patterning and morphogenesis of Drosophila
embryos. PLoS Genet 2(8): e134. DOI: 10.1371/journal.pgen.0020134
Introduction
RNA silencing represents an important regulatory mech-
anism of gene expression, in which short RNAs regulate
mRNA stability and translation or control transcription via
chromatin modiﬁcation [1]. Such short RNAs include small
interfering RNAs (siRNAs) and microRNAs (miRNA). Small
RNAs are produced from larger precursors by RNase III–type
endonucleases, called Dicer [2,3]. Processed small RNAs are
incorporated into the RNA-induced silencing complex (RISC,
also called miRNP in the case of miRNAs) [4,5]. Active RISC
either catalyzes the cleavage of the cognate target mRNA or
interferes with its translation. RNA silencing directed by
siRNAs has been implicated in heterochromatic silencing in
various organisms from yeast to humans [6]. miRNAs are
involved in a variety of biological processes such as cell
proliferation, cell death, developmental timing, and embry-
onic patterning [7].
Biochemical and genetic analyses have revealed that the
molecular mechanisms underlying RNA silencing crucially
require proteins from the Argonaute family [8]. Argonaute
proteins are essential components of RISC and represent the
catalytic activity of RISC in both the miRNA and the siRNA
pathway [9–14]. Argonaute proteins are highly conserved and
share at least two functional domains, a PAZ and a PIWI
domain [8]. The PAZ domain forms a nucleic acid–binding
pocket and binds small RNAs [15,16]. The PIWI domain
shares structural similarities with ribonucleases and contains
an activity that degrades cognate RNAs [13,14,17–19].
The Drosophila genome encodes ﬁve Argonaute family
members: Aubergine (Aub), Piwi, Ago1, Ago2, and Ago3
[8,20,21]. Ago2 differs from the other Drosophila Argonautes
in that it has a unique amino-terminal extension rich in
glutamines (37% of all residues are glutamine). Almost two-
thirds of this domain is made up of tandem copies of two
types of glutamine-rich repeats (GRRs). In other proteins,
glutamine-rich domains can promote protein aggregation
such as the PolyQ domains in the mutant forms of Huntingtin
linked to neurodegeneration or the PrD domains of many
yeast prions [22,23]. For Ago2, however, the functional
signiﬁcance of this domain is unknown.
In Drosophila, siRNA-induced and miRNA-induced silencing
vary in their requirement for different Argonaute and Dicer
genes. Ago1 is required for miRNA-induced RNA silencing
but is dispensable for siRNA-triggered RNA cleavage in vitro
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has demonstrated an essential function of Ago2 for RNAi
[9,11], but depletion of Ago2 does not impair miRNA-
directed RNA cleavage in vitro. A similar distinction has
been detected at the level of Dicer: Dicer-1 (Dcr-1) mutants are
defective in processing pre-miRNAs, while Dicer-2 (Dcr-2)
mutants are defective in processing siRNA precursors [24].
The fact that null mutations in Dcr-2 are homozygous viable
and fertile suggests that siRNA-triggered RNAi is not
essential for normal development. In contrast, homozygous
Dcr-1 null mutants are lethal supporting the model that
regulation through miRNAs is a crucial mechanism during
embryogenesis.
We have characterized the maternal-effect mutation drop
out (dop), which causes speciﬁc developmental defects at the
midblastula transition. The mutant embryos show a transient
block in membrane growth and fail to undergo a devel-
opmental switch in the microtubule-based polarized trans-
port of lipid droplets. Surprisingly, we ﬁnd that dop mutations
represent special alleles of ago2. Two independently gener-
ated dop alleles reduce the copy number of the GRRs,
providing the ﬁrst evidence of a functional role of this
domain. These mutations render Ago2 only partially defec-
tive in siRNA responses. However, these alleles interact
genetically with Ago1, suggesting the possibility of crosstalk
between Ago1- and Ago2-mediated pathways. This conclusion
is further supported by double-mutant analysis using loss-of-
function alleles of ago2 and ago1; we demonstrate that the two
gene products function redundantly in embryonic pattern-
ing. Our results reveal novel functions of Argonaute proteins
in early embryogenesis and suggest a regulatory role for the
GRR domain of Ago2.
Results
The dop Mutation Affects Membrane Growth during
Cellularization
To dissect the mechanisms that establish epithelial cell
polarity, we reexamined the previously described female-
sterile mutation dop [25]. Flies homozygous or hemizygous for
dop
1 are viable, but embryos from dop
1 homozygous mothers
do not hatch and display defects in larval cuticle formation,
reminiscent of bazooka or crumbs alleles, mutations that disturb
the formation of the embryonic epidermis (see below). Using
videomicroscopy of living embryos, we found that these
embryos display severe morphological defects about 3 h after
fertilization, at the time of the midblastula transition (MBT).
The MBT is marked by the onset of substantial zygotic
transcription and is accompanied by dramatic morphological
changes. One of the most striking MBT-speciﬁc processes in
Drosophila is cell formation, and it is this process that is
abnormal in dop mutants. In the wild-type, the ﬁrst 13
cleavage divisions of the zygote take place without cytokine-
sis, and during cycle 14, the time of the MBT, polarized
growth of the plasma membrane transforms the syncytial
embryo into the polarized blastoderm epithelium [26]. In the
dop
1 mutant embryos, we detected no signiﬁcant differences
to the wild-type up to cycle 13 (not shown). But the initiation
of membrane growth in cycle 14 was signiﬁcantly delayed
(Figure 1A–1C). The defect in membrane growth was also
evident by immunolabeling for an endogenous marker for
cleavage membranes, Neurotactin (Nrt) (Figure 1D and 1E).
dop
1 represents the ﬁrst example of a maternal-effect
mutation that speciﬁcally affects morphogenetic events at
the MBT.
Cell formation is initiated by the generation of two
membrane subdomains: the furrow canal and the basal
junction [27]. In dop
1 embryos, Slam, a marker for the furrow
canal [28], did not accumulate in between the individual
nuclei but remained associated with the egg cortex in an
irregular pattern throughout the initial stages of cell
formation (Figure 1F–1I). Similarly, Arm, a marker for basal
junctions, failed to accumulate in a typical honeycomb-like
pattern but remained diffusely distributed over the egg
cortical cytoplasm (Figure 1J–1M). We conclude that dop
1
affects early morphological processes during the MBT,
namely, initiation of the furrow canal, formation of basal
junctions, and membrane growth.
The morphogenetic events during the MBT in Drosophila
are controlled by a limited number of zygotic genes [29]. We
therefore tested whether the dop
1 phenotype results from
defective expression of Slam, a known zygotic regulator of
cellularization. Zygotic mutants for slam display a delay in
cellularization very similar to the one of dop
1 embryos [28,30].
Yet levels of both slam transcript and of Slam protein were
normal in dop
1 embryos, as were their spatial expression
patterns (Figure 1F–1I and unpublished data). Thus, the
phenotype of dop
1 embryos does not reﬂect a defect in the
regulation of slam expression.
Membrane growth during cellularization requires an intact
microtubule cytoskeleton [31,32]. Thus, the cellularization
defects in dop
1 might indicate problems with microtubule-
based transport. Since the mechanisms of microtubule
transport during cellularization are not well understood, we
instead examined a well-deﬁned microtubule-based transport
process in the early embryo, the motion of lipid droplets.
dop
1 Embryos Display Aberrant Microtubule-Based
Transport of Lipid Droplets
When examined by videomicroscopy, dop
1 embryos were
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Synopsis
Cells employ diverse mechanisms to control the activity of their
genes, and over the last ten years, a new strategy for gene
regulation called RNA silencing has been discovered. Central
components responsible for RNA silencing are Argonaute proteins.
While many of the molecular properties of Argonaute proteins have
been uncovered, little is known about their function in living
organisms. In Drosophila, it has been puzzling that mutations in
individual Argonaute proteins lead to surprisingly mild defects in
development, although RNA silencing had been suggested to play
major roles in gene regulation. Meyer and coworkers describe that
Ago1 and Ago2, two Argonaute family members in Drosophila,
function in a redundant fashion. Previously, these two proteins were
demonstrated to mediate distinct pathways of RNA silencing. The
authors show that in early embryos Ago1 and Ago2 work together
in two fundamental processes: the generation of polarity within
cells, by controlling the unequal distributions of proteins and cell
organelles, and the polarity of tissues, by modulating an important
cell-cell signaling pathway. These results connect the activity of
Argonaute proteins and by extension the mechanisms of RNA
silencing with central problems of cell and developmental biology,
namely the regulation of polarity in cells and tissues.PLoS Genetics | www.plosgenetics.org August 2006 | Volume 2 | Issue 8 | e134 1226
Function of argonaute Genes in Drosophilaabnormally transparent from gastrulation onward (Figure 2A
and 2B). Such altered transparency can be a signature of
mislocalized lipid droplets, as cytoplasm ﬁlled with lipid
droplets is opaque [33,34]. In the wild-type, lipid droplets are
present throughout the embryo periphery after gastrulation.
In contrast, in dop
1 embryos, they were highly enriched
basally, around the yolk sac (Figure 2C and 2D).
In the wild-type, droplet distribution along the apical-basal
axis is temporally coordinated with cellularization: droplets
are located throughout the periphery in syncytial stages and
are transported basally early during cycle 14 and back
apically during gastrulation [33]. As a result, the periphery
ﬁrst becomes transparent (cytoplasmic clearing) and then
turns opaque again. Because wild-type and dop
1 embryos
displayed very similar transparency up until the end of cycle
14, the initial basal droplet transport appeared normal. To
Figure 2. dop
1 Compromises Polarized Microtubule-Based Transport
(A, B) During germband extension, the periphery of dop
1 embryos (B) is much more transparent than that of wild-type embryos (A).
(C, D) Lipid droplets (green) were stained with the droplet-specific fluorescent dye Nile Red, and their distribution was recorded by epifluorescence
microscopy. In the wild-type, lipid droplets are found throughout the periphery. In the mutant, lipid droplets are accumulated around the central yolk.
(E–H) Males homozygously deleted for halo were crossed to dop
1 heterozygous (E, G) or homozygous (F, H) females to generate embryos with reduced
halo expression. In these embryos, droplet distribution was assessed by overall transparency (E, F) or staining for the regulator Klar (green) (G, H). In late
cycle 14, embryos from dop
1 homozygous mothers have a more transparent periphery and tighter basal accumulation of Klar puncta.
(I, K) Overall expression and distribution of Klar (green) is very similar in wild-type (I) and ago2
dop1 embryos (K). (L) In centrifuged early embryos, lipid
droplets accumulate in a distinct layer, just above nuclei (blue). In centrifuged dop
1 embryos, Klar (green) is highly enriched in the droplet layer, just as
in the wild-type [36], indicating that it is physically associated with the droplets. Scale bars represent 200 lm in (A) and 80 lm in (L).
(G–L) Nuclei (blue) were labeled with Hoechst 33258.
DOI: 10.1371/journal.pgen.0020134.g002
Figure 1. dop
1 Affects Cell Formation in the Early Embryo
(A–C) Membrane extension is strongly reduced in dop
1 embryos.
(A, A9) Frames taken from a video-sequence of a wild-type embryo. In the wild-type, membranes grow slowly for the first 30 min of cycle 14 interphase
[slow phase (A)], and then growth speeds up considerably [fast phase (A9)].
(B, B9) dop
1 mutant embryo from a video-sequence at corresponding time points. The shape of the nuclei (circles) and the extent of furrow progression
are indicated (bars).
(C) The progression of the cleavage furrow was plotted against the time after the beginning of mitotic cycle 14. Note that compared to the wild-type
furrow progression is significantly slower in embryos derived from homozygous (dop
1/dop
1) or hemizygous [dop
1/Df(3L)XG9] dop
1 females, within the
first 30 min of cellularization. In dop
1 homozygotes, membranes advanced 0.07 lm/min during slow phase, compared to 0.25 lm/min in the wild-type.
In hemizygous dop
1 embryos, membrane formation was even more severely impaired; it was slower during both slow and fast phase.
(D, E) Immunostaining of the endogenous membrane protein Neurotactin (Nrt; green) and DNA (blue) in wild-type (D) and dop
1 (E) mutant embryos
during progression of cell formation (from left to right panel). While Nrt associates with the egg cortex in both cases, Nrt positive cleavage membranes
in dop
1 mutant embryos are absent until fast phase.
(F–I) Immunostaining with Slam antibodies (red) indicates the presence of furrow canals in wild-type (F, H) and dop
1 (G, H) mutant embryos (F, G: optical
cross section; H, I: tangential optical section) at progressively older stages of cell formation.
(F, H) In the wild-type, formation of the furrow canal can be seen as a regular array of loop-like structures beginning with nuclear elongation.
(G, I) In dop
1 mutant embryos, Slam localization does not resolve into this regular array and forms an unevenly distributed network apical to the nuclei.
(J–M) Immunostaining with Arm antibodies (red) indicates the positioning of the basal junctions; two timepoints are shown in each panel: beginning of
slow phase to the left and beginning of fast phase to the right.
(J, L) In the wild-type, Arm accumulates adjacent to the furrow canals and forms a honeycomb pattern as seen in surface view.
(K, M) In dop
1 mutant embryos, Arm remains apical and does not accumulate in basal junctions. Fixed embryos were staged by the extent of nuclear
elongation, as described by Lecuit et al. [30].
DOI: 10.1371/journal.pgen.0020134.g001
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Function of argonaute Genes in Drosophiladetermine when the difference in droplet transport between
these genotypes arises, we employed embryos in which
expression of the directionality determinant Halo was
reduced. Under these conditions, basal transport is slower
and less complete [35]. Embryos that expressed only a single
copy of halo appeared similar early in cycle 14 whether they
were derived from dop
1 homozygous or heterozygous mothers
(not shown), but late in cycle 14, lipid droplets in embryos
from dop
1 homozygotes accumulated more basally (Figure 2E–
2H), as judged by both higher embryo transparency and
tighter basal accumulation of Klar, a droplet-associated
regulator [36]. Thus, droplet distribution in dop
1 becomes
abnormal late in cycle 14, and droplets fail to switch from
basal to apical transport.
The abnormal droplet distribution in dop
1 embryos is
reminiscent of the droplet-transport defect in embryos
mutant for the regulator Klar [33]. However, Klar expression
and distribution were very similar between wild-type and dop
1
embryos (Figure 2I and 2K), and Klar was physically
associated with lipid droplets in the mutant, as it is in the
wild-type (Figure 2L). To test whether Klar function was
affected in dop
1 embryos, we took advantage of the
observation that in embryos that completely lack Halo the
direction of net transport in early cycle 14 depends on Klar: it
is apical in the presence of Klar but basal in the absence of
Klar (unpublished data). When we abolished Halo expression
pharmacologically, droplet motion was net apical in wild-type
and dop
1 embryos but net basal in klar embryos (Figure S1).
Thus, Klar is not only expressed but also functional in dop
1
embryos. Expression and function of Halo also appeared to
be unaffected in dop
1 embryos (Figure S2).
Lipid droplets move bidirectionally along microtubules,
and their apical-basal distribution results from the relative
contribution of plus- and minus-end motion [33]. Altered
droplet distribution in dop
1 embryos was not due to lack of
droplet motion per se since droplets moved bidirectionally
before, during, and after cellularization (unpublished data).
This observation indicates that the motors driving droplet
transport as well as the microtubule tracks are grossly intact.
We conclude that the basic machinery responsible for droplet
motion is intact and that dop
1 alters a speciﬁc aspect of
transport resulting in faulty regulation of net transport
direction.
In summary, the dop
1 mutation reveals the existence of a
maternally established control mechanism to regulate speciﬁc
events at the MBT: formation and growth of membrane at the
start and during cellularization, and a developmentally
r e g u l a t e ds w i t c hi no r g a n e l l et r a n s p o r ta tt h ee n do f
cellularization. Importantly, dop
1 does not pleiotropically
impair embryogenesis per se; we did not observe devel-
opmental defects prior to the MBT. It remains to be
established whether the defects in the dop
1 mutants reﬂect a
common problem with microtubule-based transport or
independent molecular mechanisms. Uncovering the under-
lying molecular mechanisms should provide new insights into
the regulation of the morphogenetic events associated with
the MBT.
dop Is Allelic to ago2
As a ﬁrst step toward characterizing this new mechanism
controlling the MBT, we sought to identify the gene affected
by the dop
1 mutation. Using chromosomal deletions, we
mapped dop
1 to a 45-kb genomic region that contains six
predicted genes (Figure 3). P-element insertions within this
interval were employed to produce small deletions by male
recombination [37]. The majority of the recombinant
chromosomes that failed to complement dop
1 were obtained
with two insertions that ﬂank the genes for CG7739 or ago2
(Figure 3B and unpublished data). It seemed therefore likely
that dop is represented by one of these two genes. We
generated rescue constructs in which the maternal a4-
tubulin67C promoter drives cDNAs for CG7739 or ago2. The
mat::tub-ago2 transgene, but not mat::tub-CG7739, rescued
embryos derived from dop
1 mothers to viability (Table 1).
The conclusion that dop
1 is an allele of ago2 is supported by
an independent allele, dop
46, that we created by transposase-
induced reversion of EP(3L)3417, a P-element inserted within
the 59 UTR of ago2. Females homozygous or hemizygous for
dop
46 are sterile, and their embryos can be rescued to viability
by expression of the mat::tub-ago2 transgene. Embryos derived
Figure 3. Genetic and Molecular Analysis of the ago2
dop Mutations
(A) Genetic characterization of the dop genomic region. Deletion mapping identified the cytological interval 71D1-E1 as the region uncovering the dop
locus. Black bars represent the deleted regions. Df(3L)BK10 represents the deletion that was used in the initial screen for female-sterile mutations by
Galewsky and Schulz [25]. The distal breakpoint of Df(3L)XG9 is to the right of the mex1 gene (based on PCR mapping) and the proximal breakpoint is to
the left of CG7739 (based on complementation of l(3)s1754 and PCR probing for CG7739).
(B) Genomic organization of the 71D1 to 71E3 region as predicted from the release 3 of the annotated genomic sequence by the Berkeley Drosophila
Genome Project. The 45-kb region contains six predicted genes and three P-element-insertions. The P-insertions P(l(3)s1754), P(l(3)03576, and
PfEPgEP3417 were utilized to produce small deletions by male recombination (unpublished data).
DOI: 10.1371/journal.pgen.0020134.g003
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46 homozygous or hemizygous females showed
defects in early development very similar to embryos from
dop
1 mothers. dop
46 failed to complement both the lethality
and the cellularization defects of dop
1. We conclude that dop
mutations represent mutant alleles of ago2. In the following,
these alleles will be called ago2
dop1 and ago2
dop46, respectively.
Embryos derived from homozygous or hemizygous mutant
mothers will be referred to as ago2
dop embryos.
The phenotype of ago2
dop1 strongly suggests that this
mutation speciﬁcally disturbs processes at the MBT, as it
did not impair syncytial development of the embryo. To test
this notion, we used the Gal4/UAS system to drive expression
of ago2 cDNA at the onset of zygotic transcription. We found
that zygotic expression of Ago2 was sufﬁcient to rescue
ago2
dop1 mutant embryos to viability (Table 2). We therefore
conclude that the major defects in ago2
dop mutant embryos
are due to compromising a zygotic function and are not
simply the consequences of earlier defects in oogenesis.
ago2
dop1 Impairs RNAi
Ago2 is known to be essential for RNAi mediated through
siRNAs [9,11]. Is abnormal siRNA-induced RNAi the molec-
ular basis for the severe organismal phenotypes in the ago2
dop
alleles? To test whether ago2
dop mutations impair RNAi, we
employed DIAP1
RNAi, a double-stranded RNA (dsRNA) con-
struct against the cellular caspase inhibitor DIAP1 [38]. When
this construct is expressed in the developing eye, DIAP1 levels
are reduced, causing cells to die by apoptosis; as a conse-
quence, the eyes are signiﬁcantly smaller (Figure 4A and 4B).
In this experimental system, the efﬁciency of RNAi induced
by long dsRNA can be assessed by the size of the eye: efﬁcient
RNAi results in severely reduced eyes; complete disruption of
RNAi leads to normal-sized eyes. In ﬂies with only a single
copy of the Dcr-2 gene, this phenotype was partially sup-
pressed (Figure 4C), conﬁrming that the activity of DIAP1
RNAi
depends on siRNA production through Dcr-2. We also tested
a reported null allele of ago2 in this assay: ago2
51B has a
deletion of exons 1 and 2 and completely abolishes siRNA-
directed RNAi in embryo extracts [11]. In ﬂies homozygous
for ago2
51B, the DIAP1
RNAi phenotype was completely sup-
pressed (Figure 4D). Together these results are consistent
with the biochemical requirements of Dcr-2 and Ago2 for
RNAi [11,24].
The ago2
dop1 mutation impaired RNAi only partially.
Animals heterozygous for ago2
dop1 did not exhibit a signiﬁcant
modiﬁcation of the DIAP1
RNAi phenotype (Figure 4E). We
observed mild suppression in ago2
dop1 homozygotes and
stronger suppression in ago2
dop1 hemizygotes, but even in
the most extreme cases suppression was less pronounced than
for ago2
51B (Figure 4F and 4G). Thus, the ago2
dop1 mutation
compromises, but does not abolish, Ago29s function to
mediate RNAi induced by long dsRNA.
When we examined ago2
51B mutant embryos, in which
RNAi is completely abolished, the embryos appeared largely
normal morphologically, consistent with previous reports on
the effect of another ago2 null allele, ago2
414 [11,39]. As
described recently, a minor fraction of the embryos derived
from mothers homozygous for ago2
51B (44% of embryos, n ¼
786) or ago2
414 (33% of embryos, n ¼ 200) exhibit defects
during syncytial cleavages [40]. Embryos displaying syncytial
defects were grossly abnormal and did not develop beyond
that stage. All other embryos obtained from ago2
51B or ago2
414
homozygous mothers developed normally, and cellularization
of these embryos was indistinguishable from the wild-type
(Figure S3). We also analyzed the distribution of lipid droplets
in ago2
51B homozygous embryos and found no defects in net
transport of droplets (Figure S4). Thus, it seems unlikely that
the defects in membrane growth and microtubule transport
in ago2
dop1 embryos are due to a failure in the siRNA pathway.
This conclusion is further supported by the lack of
morphogenesis defects in Dcr-2 mutants. Lee et al. [24]
reported that mutations in Dcr-2 are viable, and we found that
embryos derived from Dcr-2 homozygotes exhibit normal
cellularization and net lipid-droplet transport (unpublished
data). We therefore conclude that ago2
dop mutations alter the
activity of the ago2 gene and that the forms of Ago2 encoded
Table 1. Rescue of dop
1 Mutants by Maternally Expressed Full-
Length ago2 cDNA
Genotype Larvae
Hatched (n)
%
OrR 3 OrR (control) 50 (50) 100
ago2
dop1/ago2
dop1 3 OrR 0 (112) 0
mattub-ago2; ago2
dop1/ago2
dop1 3 ago2
dop1/ago2
dop1 162 (533) 31.4
mattub-ago2; ago2
dop1/ago2
dop1 3 OrR 143 (564) 27.7
Eggs were collected from crosses indicated (genotype of mothers [left] and fathers [right])
and the number of hatched larvae was examined (OrR ¼ Oregon R). n ¼ total number of
eggs analyzed. Rescue by the mat::tub-ago2 transgene is highly efficient as dop
1
homozygotes carrying the transgene can be maintained as a stock.
DOI: 10.1371/journal.pgen.0020134.t001
Table 2. Genetic Interaction of ago2
dop1 with ago1: Distribution of Larval Cuticle Phenotypes
Genotype
a Normal Class I Class II Class III Class IV n
ago2
dop1/Df(3L)XG9 0 4 15 29 52 202
ago2
dop1/ago2
dop1 0 31 12 10 47 213
ago1
k08121/Cy O; ago2
dop1/ago2
dop1 0 7 10 13 70 509
UAS::Ago2/þ; ago2
dop1/ago2
dop1 mat::Gal4 2 15 22 22 39 222
UAS::Ago1/þ; ago2
dop1/ago2
dop1 mat::Gal4 1 32 18 10 39 731
Numbers represent percentages of observed phenotypes; for classification of cuticle phenotypes see Figure 5. Severity of defects increases from left to right: ‘‘normal’’ represents hatching
first instar larvae. Note that in the last two experiments only 50% of the embryos contain both the UAS and the Gal4 transgenes, which are together required for rescue.
aEmbryos are derived from mothers of the indicated genotypes crossed to fathers of the same genotype
DOI: 10.1371/journal.pgen.0020134.t002
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dop alleles might interfere with a pathway distinct
from siRNA-triggered RNAi.
ago2 Interacts Genetically with ago1
One possibility to explain the early embryonic phenotype
of ago2
dop mutants is that mutations in one Argonaute family
member might affect the function of another. A good
candidate for this other Argonaute gene is ago1. While
biochemical studies have concluded that Ago1 is dispensable
for siRNA-triggered RNAi [11], it has also been reported that
mutations in ago1 mildly suppress siRNA-triggered RNAi in
the embryo [21]. Consistent with the latter report, we found,
using the DIAP1
RNAi reporter construct, that reduction of
ago1 gene dosage mildly suppresses the RNAi response in the
compound eye (Figure 4H). This suppression can even be
enhanced by ago2
dop1; ﬂies that are heterozygous for ago1 and
homozygous for ago2
dop1 exhibit a stronger suppression of the
DIAP1
RNAi phenotype as either mutation alone (Figure 4I and
4J). We conclude that ago1, at least in the eye, is required for
siRNA-mediated RNAi and thus Ago1 and Ago2 might have
partially overlapping functions.
Given the interaction of ago1 and ago2 in siRNA-mediated
silencing, it is conceivable that these two genes also have
overlapping roles at the MBT. Indeed, reduction of ago1
function enhanced the cellularization phenotype of ago2
dop1
homozygotes: membrane growth was strongly compromised,
and only very little membrane extension was observed (Figure
5A). This enhanced defect in cell formation was also evident
from a more severe disruption of larval cuticle formation
(Figure 5B–5F and Table 2). Remarkably, zygotic expression
of UAS::ago1 was sufﬁcient to ameliorate the cuticle defects of
ago2
dop1 mutant embryos and to allow some of them to
develop into adult ﬂies (Figure 5F and Table 2). Thus, the
severity of the ago2
dop1 phenotypes is sensitive to the levels of
expression of ago1, suggesting that in ago2
dop1 mutants Ago1
function has become limiting.
Since the overlapping functions of Ago1 and Ago2 were
detected using our ago2
dop alleles, the question arises of
whether this genetic interaction is an unusual feature of these
particular alleles or whether the two genes cooperate more
generally. We were able to distinguish between these
possibilities when we discovered a novel phenotype of ago1
and ago2 in larval cuticle formation (Figure 6). Embryos
homozygous for both ago1
k08121 and ago2
dop1 displayed cuticles
with characteristic patterning defects, similar to those
described for mutations in the wingless (wg) or arm genes
(Figure 6B and 6C). This strong segment-polarity defect was
also observed in embryos double mutant for the two loss-of-
function alleles ago1
k08121 and ago2
51B (Figure 6D and 6E).
Because such defects are never observed in single mutants for
ago1 or ago2 ([20]; W. J. Meyer and H. A. J. Mu ¨ller, unpublished
data), these data indicate that ago1 and ago2 act in a partially
redundant fashion. In addition, these observations reveal a
previously unrecognized essential role of Argonaute genes in
segmental patterning.
To identify the molecular basis for this patterning defect,
we examined the expression of Wg, Engrailed (En), and Arm
proteins in the double mutants. In the wild-type, Wg and En
are initially expressed in 14 nonoverlapping segmental stripes
(Figure 6G and 6M). In response to Wg signaling, levels of
cytoplasmic Arm increase and En expression is maintained in
the receiving cells (Figure 6J; [41]). In embryos zygotically
Figure 4. Requirement of ago2 and ago1 for siRNA-Mediated RNAi
Effects of mutations on siRNA-mediated RNAi were assayed using a UAS construct that reduces the function of the cell death inhibitor DIAP1 by
expression of dsRNA (DIAP1
RNAi: GMR::Gal4,UAS::DIAP1
RNAi) [38]. DIAP1
RNAi in the compound eye leads to the loss of cells and reduces the normal size of
the eye. Scanning EM micrographs of compound eyes of 2- to 4-d-old females of the following genotypes are indicated: (A) wild-type compound eye;
(B) GMR::Gal4, UAS::DIAP1RNAi/CyO; (C) GMR::Gal4, UAS::DIAP1
RNAi/dcr-2
L811fsX; (D) GMR::Gal4, UAS::DIAP1
RNAi/CyO; ago2
51B/ago251B; (E) GMR::Gal4,
UAS::DIAP1RNAi/CyO; ago2
dop1/TM6; (F) GMR::Gal4, UAS::DIAP1
RNAi/CyO; ago2
dop1/ago2
dop1; (G) GMR::Gal4, UAS::DIAP1
RNAi; ago2
dop1/Df(3L)XG9; (H)
GMR::Gal4, UAS::DIAP1RNAi/ago1
K08121; (I) GMR::Gal4, UAS::DIAP1
RNA/ago1K08121; ago2dop1/TM6; and (J) GMR::Gal4, UAS::DIAP1RNAi/ago1
K08121; ago2
dop1/
ago2
dop1.
DOI: 10.1371/journal.pgen.0020134.g004
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k08121 and ago2
51B, Wg protein was
not detected in extended germ-band stages (Figure 6H). The
lack of expression of Wg protein in these embryos is sufﬁcient
to result in the observed patterning defects. As a consequence
of the lack of Wg protein expression, cytoplasmic Arm stripes
are not present and En expression is not maintained in these
embryos (Figure 6K and 6N). This genetic interaction
between ago1 and ago2 alleles indicates a partially redundant
function of the two Argonaute family members in the positive
regulation of Wg protein expression in the early embryo.
Since Ago1 is an essential component of the miRNA-
triggered RNA silencing, we reasoned that the observed
partial redundancy with Ago2 might reﬂect a function of
Ago2 in the miRNA pathway. If this assumption were correct,
ago1 might exhibit a similar genetic interaction with
mutations in other crucial components of the miRNA
pathway. The best candidate to test for this interaction is
Dcr-1, because Dcr-1 is essential for the processing of pre-
miRNAs [24]. Indeed, we found that double mutants of the
loss-of-function alleles ago1
k08121 and Dcr-1
Q1147X exhibit the
same segment-polarity cuticle phenotype and lack of Wg
expression as ago1, ago2 double mutants (Figure 6F, 6I, and
6L). In ago1, Dcr-1 double mutants, Wg protein was not
detected even in gastrula stages (Figure 6O and 6P). Embryos
singly mutant for Dcr-1
Q1147X or double mutant for Dcr-
2
L811fsX and Dcr-1
Q1147X do not show such defects (Figure 6A
and unpublished data). Because a reduction in the zygotic
expression of two major components of the miRNA pathway
can result in segment polarity defects, these data suggest an
as-of-yet unrecognized requirement of miRNA function for
segmentation and the regulation of Wg expression.
In summary, our genetic analysis has uncovered several
instances in which Ago1 and Ago2 appear to act in a partially
redundant and partially overlapping manner: in siRNA-
mediated RNA interference, in the regulation of Wg
expression in the early embryo, and for morphological
changes associated with the MBT.
Biochemical Interaction of Ago1 and Ago2
What is the molecular basis for the observed genetic
interaction between ago1 and ago2? It is conceivable that
depletion of Ago2 leads to a reduction in the levels of Ago1 or
shared components of the RISC assembly machinery. To
investigate this possibility, we analyzed Ago1 protein levels in
ago2 mutants by Western blotting. We ﬁnd that Ago1 protein
levels are wild-type in embryos derived from ago2
dop1
homozygotes, as well as from ago2
51B or ago2
414 homozygotes
(Figure 7A). We also tested the levels of Dcr-1 and Locqua-
cious (Loqs), a dsRNA binding protein that can be part of a
protein complex with Ago1 and Dcr-1 and is important for
the function of Dcr-1 to process pre-miRNAs [42,43]. Like in
the case of Ago1, Loqs and Dcr-1 protein levels were largely
unimpaired in ago2
dop1, ago2
51B,o rago2
414 homozygotes
(Figure 7B and 7C). We therefore conclude that mutations
in ago2 do not result in global changes of the protein levels of
Ago1, or shared components involved in RISC assembly.
Our genetic data demonstrate that Ago1 and Ago2 act in a
partially redundant fashion in siRNA-triggered RNAi as well
as during morphogenesis and pattern formation in the
Figure 5. Genetic Interaction of ago2
dop1 with ago1
Reduction of the ago1 gene doses enhances the ago2
dop1 cellularization phenotype.
(A) Kinetics of membrane extension during cellularization in embryos derived from ago1
K08121/CyO; ago2
dop1/ago2
dop1 females. Embryos from Kr
If/CyO;
ago2
dop1/ago2
dop1 display the characteristic dop delay in membrane growth during cellularization (purple line; n¼9) relative to the wild-type (Oregon R;
black line; n¼6). Embryos from ago1
K08121/CyO ; ago2
dop1/ago2
dop1 mutants (blue line; n¼9) show a strongly reduced furrow progression even during
fast phase.
(B–E) Embryos derived from mothers homozygous or hemizygous for ago2
dop1 do not hatch and produce abnormal larval cuticles, which can be
grouped into four classes. (B) Class I (continuous cuticle): such embryos form a continuous cuticle with more or less severely affected denticle belts. (C)
Class II (shield): such embryos produce a shield of continuous cuticle, reminiscent of neurogenic mutants. (D) Class III (crumbs-like): such embryos
produce only small globular remnants of cuticle, reminiscent of mutations in genes required for epithelial polarity, such as crumbs. (E) Class IV (no
cuticle): embryos in this class did not produce any cuticle at all.
(F) Graphic presentation of the distribution of cuticle phenotypes of the different classes; color codes are indicated on (B–E).
Original data are presented in Table 2.
DOI: 10.1371/journal.pgen.0020134.g005
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be that Ago1 and Ago2 have overlapping functions as part of
a common protein complex. To examine this possibility, we
used Ago2 antibodies to immunoprecipitate Ago2 protein
complexes from embryo lysates and assayed for the presence
of Ago1. We found that anti-Ago2 antibodies coprecipitate
Ago1 protein from these extracts (Figure 7D). These results
indicate that subpopulations of Ago1 and Ago2 proteins are
present in a common complex, consistent with the idea that
Ago1 and Ago2 have overlapping functions.
ago2
dop Mutations Affect Glutamine-Rich Repeats in the
Amino-Terminus of Ago2
Our data on the ago2
dop alleles indicated that these
mutations compromise Ago29s function in the siRNA path-
way and might also disturb the normal function of Ago2 such
that it negatively interferes with Ago1 function. This suggests
that a molecular characterization of the ago2
dop mutations
should give insight into the mechanism by which Ago2 and
Ago1 interact. Our molecular analysis indicates an important
role for the previously uncharacterized amino-terminal GRR
domain (Figure 8). This domain is rich in glutamines and is
largely composed of four imperfect copies of the 6–amino
acid (aa) repeat GRR1 and 11 imperfect copies of the 23-aa
repeat GRR2 (Figures 8B and S5).
Whenwecomparedago2expressionbyRT-PCRorNorthern
blotting, we found that ago2 mRNA was expressed in ago2
dop1
butthatitssizewasslightlyshorterthaninthewild-type(Figure
8A). Importantly, despite the size difference, the total levels of
ago2 transcript are the same in the wild-type and ago2
dop1
mutants (Figure 8A). We also assessed whether the ago2
dop1
mutationaffectsthetotalproteinlevelsofAgo2andfoundthat
Ago2 protein levels are unimpaired in the mutant (Figure 8A).
Thus, the ago2
dop mutation does not affect the normal
accumulation of Ago2 mRNA or protein in the embryo.
We found that the genomic sequence of ago2
dop1 exhibits a
69-nucleotide in-frame deletion in exon 3 that leads to the
loss of exactly one copy of GRR2 (Figure 8B). The molecular
lesion in ago2
dop46 is an 18-nucleotide in-frame deletion in
exon 2, which results in the loss of one copy of GRR1 (Figure
Figure 6. Requirements of ago1, ago2, and Dcr-1 for Segmentation
Segment-polarity defects in zygotic ago1, ago2 homozygous mutant embryos are evident in alterations of the larval cuticle (A–F) or the pattern of
immunolabeling (G–O). All embryos are oriented with their anterior to the left.
(A–F) Parents of the indicated genotypes were mated and the cuticles of those embryos that failed to hatch were examined: (A) Embryos double
mutant for dcr-2
L811fsX and dcr-1Q1147X do not hatch, but exhibit normal cuticle differentiation. (B) Class I cuticles from ago1
K08121/CyO; ago2
dop1/ago2
dop1
mutant parents exhibit a lawn of denticles, indicative of a defect in establishing segment polarity. (C) Embryos from ago1K08121/CyO; ago2
dop1/TM6
mutant parents develop a continuous cuticle with an anterior hole and a strong segment polarity defect. (D) Embryos from ago1
K08121/CyO; ago2
51B/TM6
mutant parents or from (E) ago1
K08121/CyO; ago2
51B/ago2
51B parents show similar segment polarity defects. (F) Embryos obtained from ago1
K08121/CyO;
dcr-1Q1147X/TM6 parents also exhibit a typical segment polarity defect.
(G–N) Immunolabeling of Wg (G–I), Arm (J–L), or En (M, N), proteins in extended germband embryos (stage 9). To identify homozygous embryos,
CyO[hb::lacZ] and TM3[hb::lacZ] balancer chromosomes were used. The presence of the [hb::lacZ] transgene on the balancers results in ß-galactosidase
expression in the anterior of the embryo (J). (G, J, M) Embryos heterozygous for ago1
K08121; ago2
dop1. Wg and En proteins are expressed in 14 stripes;
cytoplasmic Arm protein is elevated in 14 stripes (J). (H, K, L) In ago1K08121; ago2
51B zygotic double mutants, Wg expression is completely abolished (H).
Cytoplasmic levels of Arm (K) are equally low in all cells of the embryo and expression of En (N) is not maintained and fades from stage 9 onward. (I, L)
Homozygous ago1
K08121; dcr-1Q1147X double mutant embryos also lack expression of Wg (I) and hence also fail to accumulate Arm (L) stripes.
(O, P) Gastrula stage ago1
K08121; dcr-1
Q1147X double mutant embryo (stage 7) (P) lacks detectable Wg protein, while Wg is expressed in heterozygous
sibling embryos (O).
DOI: 10.1371/journal.pgen.0020134.g006
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mutations in the coding region of the ago2
dop alleles. These
data provide the ﬁrst evidence that the amino-terminal
domain of Ago2 is essential for the normal function of the
protein and that mutations in the GRRs reduce Ago29s
activity in siRNA-triggered RNAi. Strikingly, even a slight
reduction in the number of either type of GRRs has severe
biological consequences. Based on the genetic interactions of
ago2
dop and ago1 and the fact that Ago1 and Ago2 are part of
the same protein complex, we propose that these mutations
in the GRR domain result in aberrant Ago2 variants that
reduce Ago2 activity and might also negatively interfere with
Ago1-dependent processes.
Amino-Terminal Glutamine-Rich Domains Are a
Conserved Feature of Insect Ago2 Proteins
Evolutionary comparisons suggest that this mechanism of
Ago2 regulation is not restricted to Drosophila melanogaster.I n
D. melanogaster, exon 3 of ago2 encodes the major portion of
the GRR domain (123 glutamates in a 333-aa stretch,
including all copies of GRR2) plus an 89-aa region conserved
in other Argonaute family members from both animals and
plants. We identiﬁed the likely corresponding exons in the
genomic sequences of six additional Drosophila species and
found the same bipartite structure (Table 3 and Figure S5A):
an amino-terminal glutamine-rich region followed by the
conserved carboxyl-terminal stretch (58% to 90% sequence
similarity). Similar amino-terminal glutamine-rich domains
of Ago2 are predicted from the genomic sequences of two
mosquito species and of honeybees (Figure S5B). Although we
have not yet examined expression outside D. melanogaster,
both exon prediction algorithms and cDNA evidence from D.
simulans and A. gambiae suggest that these glutamine-rich
regions are indeed expressed (see Materials and Methods).
Within a single species, these glutamine-rich amino-
termini typically contain multiple imperfect copies of one
to three repeat units. Yet between species, the sequences are
highly variable. This observation suggests that the primary
sequence of this region evolves rapidly, presumably by repeat
expansion and contraction [44]. Despite this variation, the
glutamine-rich character of this region is preserved in all the
species examined. This pattern is reminiscent of the yeast
prion Sup35: across yeast species, the primary sequence of the
amino-terminal prion-determining domain evolved rapidly
but retained high glutamine content [45,46]. In many
proteins, glutamine-rich regions can mediate protein aggre-
gation, and the propensity to aggregate increases with
increasing GRR copy number [47,48]. Therefore this domain
of Ago2 may similarly control the aggregation or intracellular
distribution of the protein.
Discussion
In Drosophila, two major molecular pathways of RNA
silencing have recently been deﬁned: miRNA-induced silenc-
ing and siRNA-induced RNAi [1]. At the level of Argonaute
family members, Ago1 has been implicated in miRNA
function while Ago2 was shown to be essential for siRNA
function. Our analysis provides genetic and biochemical
evidence that Ago1 and Ago2 have overlapping functions
both in siRNA-triggered RNAi and during early embryo-
genesis.
We found that, in addition to the PAZ and PIWI domains
conserved in all family members, insect orthologs of Ago2
contain an amino-terminal GRR domain. The ago2
dop alleles
allow us to probe the function of this domain. Even the subtle
alterations in these alleles have striking organismal pheno-
types, but the absence of Ago2 (in the reported null alleles)
does not. While the mutant Ago2 proteins still support siRNA
Figure 7. Analysis of Protein Levels of Ago1, Loqs, and Dcr-1 in ago2
Mutants and Coprecipitation of Ago1 and Ago2
(A) Western blot using anti Ago1 antibodies. Ago1 protein level in
embryo extracts was very similar in the wild-type (w
1118), ago2
dop1,
ago251B, and ago2
414 mutants; a-tubulin was used as a loading control.
Likewise, the protein levels of Loqs (B) and Dcr-1 (C) are largely
unimpaired in extracts from ago2
dop1, ago2
51B, and ago2
414 mutants
when compared to the wild-type (w
1118). In (C) ovary extracts were used
instead of embryo extracts.
(D) Coimmunoprecipitation experiments of Ago1 with Ago2. Ago1
protein in extracts from wild-type embryos is shown in the left lane
(input). Immunoprecipitations (IP) were performed using anti Ago1 and
Ago2Cterm antibodies or with an antibody against GFP as a control;
immunoprecipitates were analyzed by Western blotting with Ago1
antibodies. All experiments were carried out several times with
essentially the same results and representative blots are depicted. A
semiquantitative analysis of several independent Western blots is shown
in Figure S7.
DOI: 10.1371/journal.pgen.0020134.g007
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dependent processes.
A Function for the Amino-Terminal Glutamine-Rich
Repeats of Ago2
In other proteins, glutamine-rich domains have been
implicated in protein aggregation, such as in certain neuro-
degenerative diseases that involve the formation of long-lived
protein aggregates (e.g., the PolyQ domain of mutant
Huntingtin). Extension of the glutamine-rich region pro-
motes aggregation, and the length of the polyglutamine
extension correlates with the severity of the disease [22].
Glutamine-rich domains are also involved in the mechanism
by which yeast prions switch between soluble and aggregated
states [49,50]. For the translation factor Sup35, e.g., increases
in the copy number of GRRs in the prion domain favor the
aggregated, inactive state; decreases in the copy number favor
the soluble, active state [47,51]. Our genetic and molecular
analyses of the ago2
dop alleles thus raise the tantalizing
possibility that the GRRs regulate Ago2 by modulating its
aggregation state. Unlike in the polyglutamine diseases,
however, it is the reduction, rather than the expansion, of
the GRR region that leads to an aberrant Ago2 protein.
Drosophila Ago2 may therefore provide a unique inroad for
dissecting the normal organismal function of glutamine-rich
or PolyQ domains.
Since Ago2 is an essential component of protein com-
plexes, such as the RISC, control of its aggregation state is
conceivably important for its function. Mammalian Argo-
naute proteins are localized to GW bodies, cytoplasmic
compartments analogous to yeast P-bodies, which are centers
of mRNA degradation [52,53]. Central components of GW
bodies, like GW182 and decapping enzymes DCP1:DCP2, have
recently been shown to also be involved in miRNA-mediated
gene silencing in Drosophila cultured cells [54]. The presence
of both Ago1 and Ago2 in GW bodies is consistent with our
biochemical studies. An important next step for unraveling
the molecular function of the Ago2 GRR domain will be to
determine whether the ago2
dop alleles alter the recruitment of
Ago2 to particular cytoplasmic mRNA degradation com-
plexes. Such recruitment via glutamine-rich domains need
not necessarily inactivate the protein: in the translation
factor CPEB from Aplysia, a glutamine-rich prion-like amino-
terminal domain promotes protein aggregation, and it is the
aggregated form that has the greatest capacity to stimulate
translation [55].
Specificities of Ago1 and Ago2 Functions
Previousanalyseshadsuggestedasimplemodelofdivisionof
labor between Argonaute proteins in Drosophila, with Ago1
speciﬁc for miRNA-directed silencing and Ago2 involved in
siRNA-triggered RNAi. However, our genetic data add to
emerging evidence that these proteins play much broader
roles. Ago2, for example, appears to have functions beyond
siRNA-induced RNAi. It has been proposed that in larval
neurons Ago2 is recruited via the dFMR1 protein to certain
RNP complexes, including those containing the PPK1 mRNA.
This recruitment is functionally important since in the ago2
51B
allelePPK1mRNAlevelsarenotproperlydownregulated;thus,
Ago2mayplayaroleintheturnoverofspeciﬁctranscripts[39].
For Ago1, on the other hand, it is well established that it
has a function in miRNA-directed RNA silencing. But while in
biochemical assays Ago1 is not essential for siRNA function,
ago1 mutations impair the response of siRNA-triggered RNAi
in vivo ([11,21]; the present work). Our data provide further
evidence for overlapping functions of Ago2 and Ago1 in
siRNA-directed RNAi. It is possible that although Ago2 is in
principle sufﬁcient to promote siRNA-directed RNA decay,
in vivo the two proteins act in concert to make this process
more efﬁcient.
It is unlikely that the morphogenesis phenotypes of ago2
dop
mutant embryos are simply caused by disturbing the function
of Ago2 in RNAi. Unlike ago2
dop1 mutants, ago2 alleles that
Figure 8. Molecular Analysis of ago2
dop Mutations
(A) RT-PCR and Northern blot analyses of ago2 transcripts. For RT-PCR,
we used a forward primer in exon1 (E1) and a reverse primer in exon 7
(E7) as indicated in (B). This combination revealed a transcript fragment
of 3,488 nucleotides (right hand panel), which is present in w1118 (wild-
type) and ago2
dop1, but absent in ago2
51B; note the slightly faster
mobility of the E1/E7 amplicon in ago2
dop1 mutants. Northern blot using
poly-A
þ RNA prepared from w1118 or ago2
dop1 mutant embryos. A
transcript of about 4 kb is visible; note that the ago2
dop1 transcript runs
slightly faster on the gel. The amount of 18S ribosomal RNA was used as
a loading control. Levels of ago2 transcript were very similar in wild-type
and ago2
dop1. Protein levels of Ago2 were determined by Western blot
using anti-Ago2 antibodies. In extracts from embryos or ovaries levels of
Ago2 protein were largely unimpaired in ago2
dop1 mutants compared to
controls (w
1118).
(B) Genomic structure of ago2 and mutations in ago2
dop1 and ago2
dop46.
The ago2 gene spans 6,930 nucleotides of genomic DNA and contains
eight exons (RB-transcript; an alternatively spliced form, called RC
encodes for a very similar protein and is not indicated in this cartoon).
Cartoon of Ago2 protein indicates the positions of the GRR region at the
amino-terminus, a central PAZ domain, and a carboxyl-terminal PIWI
domain. The amino-terminus of Ago2 contains four imperfect GRR1
(LQQPQQ) repeats and 11 imperfect GRR2 (QGGHQQGRQGQEG-
GYQQRPPGQQ) repeats. The RB transcript codes for a protein of 1,214
aa. The protein encoded by the ago2
dop1 allele contains only 1,191 aa
and lacks one of the GRR2 repeats (repeat number 9 or 10). The ago2
dop46
mutation represents an 18-nucleotide deletion, leading to the loss of one
GRR1 and a predicted protein of 1,208 aa.
DOI: 10.1371/journal.pgen.0020134.g008
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do not cause these gross morphological defects and exhibit
problems with nuclear migration only during syncytial stages;
these phenotypes occur with a moderate penetrance such
that animals homozygous for these alleles can be kept as a
stock [11,24,39,40]. Rather, our genetic data suggest that
ago2
dop mutations compromise the function of both Ago2 and
Ago1 in controlling speciﬁc aspects of the MBT. A genome-
wide analysis of mRNA targets regulated by Argonaute
proteins has recently shown that Ago1 and Ago2 are required
for the regulation of a common set of miRNA targets, despite
the fact that only Ago1 is essential for miRNA function in
vitro [56]. In S2 cells, both Ago1 and Ago2 coprecipitate with
speciﬁc miRNAs, suggesting that not only Ago1, but also
Ago2, is able to bind miRNAs [56]. Based on our results, it is
conceivable that the interaction of miRNAs with Ago2 is
indirect, namely that Ago2 coprecipitates those miRNAs that
are bound to Ago1. While the exact mechanisms need to be
resolved, the available data provide ample support for our
conclusion that Ago1 and Ago2 act in a partially redundant
fashion during early embryogenesis.
It is conceivable that the ago2
dop mutations not only
interfere with Ago1 and Ago2 function but might affect a
common factor that is essential for both Ago1 and Ago2 or
for Argonaute protein function in general. Preliminary
observations suggest that mutations in other Argonaute
family members, piwi or aubergine, might also interact
genetically with ago2
dop alleles (unpublished data). We
currently favor the model that disrupting both Ago1 and
Ago2 function is sufﬁcient to cause the observed defects at
the MBT because ago2
dop1 mutants can be rescued by zygotic
expression of either ago1 or ago2. A test of this notion will be
to determine the phenotypic consequences for embryos when
both the maternal and zygotic expression of ago1 and ago2 has
been eliminated. In addition, the interactions of ago2
dop alleles
with other components of RNA silencing pathways should be
examined to further understand the genetic and molecular
basis for the altered activity of Ago2
dop proteins during the
MBT.
Function of Argonaute Proteins in Segment Polarity
Mutations in ago1 were originally discovered in a genetic
screen for modiﬁers of the Wg pathway [20]. Overexpression
of ago1 rescued a defect in Wg signaling induced by depletion
of cytoplasmic Arm in the wing imaginal disc. However,
because embryos homozygous for a loss-of-function mutation
in ago1 did not exhibit defects in segment polarity [20], the
relevance of Ago1 for normal Wg signaling remained unclear.
The data presented in this paper now provide an explanation
for this result. By combining loss-of-function mutations in
both ago1 and ago2, we demonstrate that the two Argonaute
genes have partially overlapping functions and together are
required for establishing segment polarity.
The function of Ago1 and Ago2 for the initial expression of
Wg protein is striking. No other genes have been identiﬁed
that are similarly essential for the general expression of Wg.
We propose two possible explanations for this result. Ago1
and Ago2 might act to eliminate a general repressor of wg
transcription or translation. In this case, it is conceivable that
speciﬁc miRNAs exist that modulate wg expression by
negatively regulating a repressive mechanism. Alternatively,
Ago1 and Ago2 might be part of RNPs that contain wg mRNA,
and the reduction in Argonaute function might interfere with
the microtubule motor-driven localization of the transcripts.
It is well established that compromising the apical localization
of wg mRNA strongly affects the intracellular distribution and
the signaling activity of the protein [57,58]. A detailed analysis
of the expression and the localization of wg transcripts will be
required to discriminate between these possibilities.
Although we have not been able to ﬁnd direct evidence that
anyoftheago2allelesinterferewithmiRNAfunctioninvivoor
invitro,itisinterestingtonotethatago1,Dcr-1doublemutants
exhibit the same segment polarity phenotypes as ago1, ago2
double mutants. This result further strengthens the notion
that in the embryo Ago1 and Ago2 might both be important
for miRNA function (see above). When we employed an eye
reporter assay to test if ago2
dop alleles interfere with the
function of the bantam miRNA, we failed to detect interactions
(Figure S6). This result might be due to the observed
redundancy of Ago2 with Ago1 function; such a redundancy
was recently described for S2 cells ([56]; Figure S6). Future
studies to identify the miRNAs involved and their targets
might yield novel insight into the regulation of Wg expression.
An alternative explanation is that our analysis has
Table 3. Amino-Terminal Glutamine-Rich Domains in Predicted Ago2 Orthologs of Insect Species
Species Number of Glutamines % Glutamine Repeats
D. melanogaster 121/316 38% 4 3 6a aþ 11 3 23 aa
D. simulans 83/237 35% 2 3 81 aa þ 2 3 25 aa
D. yakuba 125/307 41% 16 3 16 aa
D. ananassae 62/160 39% 2 3 12 aa þ 3 3 11 aa þ 2 3x1 0a a
D. pseudoobscura 27/77 35% 4 3 11 aa
D. virilis 102/318 32% 8 3 22 aa þ 5 3 13 aa
D. mojavensis 47/170 28% 4 3 31 aa
Anopheles gambiae 117/173 68% No clear repeats
Aedes aegypti 82/122 67% No clear repeats
Apis mellifera 143/337 42% 10 3 29 aa
In D. melanogaster, exon 3 of ago2 encodes the bulk of the amino-terminal glutamine-rich domain plus an amino acid stretch widely conserved among Argonaute proteins in many
species (indicated in purple in Figure S5). Genomic DNA sequences of the indicated species were examined for homologues of ago2 from D. melanogaster, and the regions corresponding
to the conserved stretch of exon 3 were identified. In each case, the genomic sequences immediately 59 have the capacity to encode glutamine-rich domains. The amino-terminal extent
of these domains was estimated using exon prediction software or cDNA evidence (see Figure S5 for details). Shown are the glutamine contents of these regions and the copy number of
distinct GRRs identified (highlighted in yellow, blue, and green in Figure S5).
DOI: 10.1371/journal.pgen.0020134.t003
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members. Intriguingly, the study of Kataoka et al. [20] showed
that ectopically expressed Ago1 constructs could suppress Wg
pathway defects even if they lacked a functional PIWI
domain. This result may suggest that Ago1 function in Wg
signaling does not involve its PIWI domain, hinting at an
uncharacterized biochemical property of Ago1. Although too
little is known at this point to speculate what such a new
function might entail, it is interesting to note that there are
intriguing connections between microtubules and the RNA
silencing machinery: Armitage, a putative helicase required
to assemble Ago2-containing RISC [59,60], is associated with
microtubules in developing oocytes; the dop alleles of Ago2
interfere with microtubule-based processes at the MBT; and
it is conceivable that Ago1 and Ago2 control the microtubule-
dependent localization of wg mRNA. Whether or not these
phenomena are explained by a shared molecular mechanism
remains to be established.
In summary, the genetic interactions described in this
paper are not easily reconciled with the model that different
pathways in gene silencing are strictly separated. Rather, our
data suggest that in the living organism these pathways, or at
least crucial components of these pathways, might act in
concert. Our observation that ago1 and ago2 cooperate in Wg
signaling provides a powerful new tool to resolve some of
these issues since now the function of these Argonaute
proteins can be assessed using a clearly deﬁned phenotype of
a well-characterized signaling pathway.
Function of Ago1 and Ago2 for the Midblastula Transition
Freshly laid Drosophila embryos contain large amounts of
maternally supplied mRNAs that encode proteins essential
for the earliest stages of embryogenesis [61]. As development
proceeds, these maternally supplied transcripts need to be
replaced by transcripts synthesized by the zygote. This
process is a hallmark of the MBT. Maternal transcripts are
degraded via two pathways: a maternal pathway switched on
at egg activation, and a zygotic pathway activated at the MBT
[62]. Our genetic analysis has shown that although ago2
dop
alleles represent maternal-effect mutations, they speciﬁcally
perturb processes shortly after the onset of zygotic tran-
scription at the MBT. We therefore propose that Ago1 and
Ago2 are key mediators of the zygotic pathway of maternal
transcript degradation. Precedence for such a scenario has
recently been provided by the identiﬁcation of the miR-430
miRNA family in zebraﬁsh. miR-430 expression is strongly
upregulated at the MBT and is required to speciﬁcally
downregulate a set of maternal mRNAs [63]. Conversely,
embryos deﬁcient for Dicer activity display defects shortly
after the MBT [63]. It remains to be determined whether
miRNAs are also required for maternal transcript degrada-
tion in Drosophila.
The known functions and structural features of Argonaute
proteins suggest a model for the underlying molecular
mechanisms. It is well established that Argonaute proteins
can act as ribonucleases and provide slicer activity in RISC
[14,17,19,64]. During early development, Ago2 and Ago1
might act as ribonucleases that cleave maternal transcripts at
the MBT. Abnormal persistence of maternal mRNAs could
then interfere with the morphogenetic events usually
triggered by zygotic transcription, such as membrane growth
during cellularization and correct directionality of lipid-
droplet transport. Alternatively, Argonaute proteins might
regulate the translation of such maternal or zygotic tran-
scripts. As we have not detected signiﬁcant changes in the
expression pattern of known regulators of membrane growth
and droplet transport (Halo, Slam, Klar), the relevant targets
are likely novel components of these regulatory pathways.
Identifying them should not only give insight into the
regulation of these fundamental cell-biological processes
but will also shed light on the mechanisms by which the
Argonaute proteins Ago1 and Ago2 work together to control
developmental events.
Materials and Methods
Drosophila genetics. Flies were kept on standard medium. The
following stocks were used: w
1118; dop
1 red e/TM6 [25]; Df(3L)XG9/TM3;
Df(3L)XG7/TM3; Df(3L)Ly,BK10/TM3; PflacWgl(3)s1754/TM3;
PfEPgAGO2
EP3417; PfPZgCrebA
03576; Ki, PfDelta2–3g99B; HfPDelta2–
3gHoP2.1,CyO/Bc; PfGawBgptc
559.1; ago2
51B [39]; ago2
414 [11]; yw
PfhsFLPg;P fneoFRTg82B; Dcr-1Q1147X/TM3; Dcr-2L811fsX/CyO [24]; yw
PfhsFLPg; D(halo)[ 3 5 ] ;klar
B [36]; ago1k08121/CyO; UAS::Ago1 [20];
GMR:Gal4; UAS::DIAP1RNAi [38]; and GMR:Gal4; GMR::hid; banEP3622.
ago2
dop46 was produced by imprecise excision of EP(3)3417. Male re-
combination experiments were done according to [65]. Egg collection
and cuticle preparations were according to standard methods.
In vivo observations and immunohistology. For in vivo observa-
tion, embryos were collected, staged on yeasted apple juice plates,
and mounted in halocarbon oil 27 (Sigma-Aldrich, St. Louis, Missouri,
United States) on microscope slides. Videomicroscopy was performed
on a Carl Zeiss (Jena) microscope equipped with Nomarski optics, and
time-lapse videos were taken on conventional videotape. For
immunohistology, embryos were either heat-ﬁxed or ﬁxed using
modiﬁed Stefanini’s ﬁxative and stained with antibodies essentially as
described elsewhere [66]. In situ hybridization with digoxygenin-
labeled antisense RNA was performed as described before [67]. Nile
Red staining was performed after Welte et al. [33]. The following
antibodies were used: rabbit anti-Slam [28]; mouse anti-Neurotactin
(Developmental Studies Hybridoma Bank, University of Iowa, Iowa
City, Iowa, United States), mouse anti-Arm [41], rabbit anti-Arm
central
(Keßler and Mu ¨ller, unpublished data), and mouse anti-KlarM [36].
All secondary ﬂuorochrome-conjugated antibodies were from Jack-
son ImmunoResearch (West Grove, Pennsylvania, United States) or
Molecular Probes (Eugene, Oregon, United State). Imaging was
performed on a Leica TCS Confocal microscope, and image
processing was performed with Adobe Photoshop (Adobe Systems,
San Jose, California, United States).
Molecular biology. Molecular cloning was performed following
standard protocols. RT-PCR was performed using OneStep RT PCR
kit (Qiagen, Valencia, California, United States) with embryonic poly-
A
þ RNA as template. Primer sequences are available upon request.
Products from RT-PCR were directly sequenced (Seqlab, Go ¨ttingen,
Germany). Northern blotting was performed using poly-A
þ RNA
isolated from 0- to 4-h-old embryos obtained from w1118 or ago2
dop1
homozygotes. The ago2 rescue construct was generated using the full-
length ago2 cDNA [9], which was cloned into CaTub_MatpolyA (a gift
of D. Ferrandon, Strasburg, France). For DNA sequencing, fragments
of ago2 genomic DNA were ampliﬁed using Pfu-polymerase (Promega,
Madison, Wisconsin, United States) and cloned using the TOPO-
cloning kit (Invitrogen, Carlsbad, California, United States). DNA
sequencing was performed by Seqlab, and sequences were examined
using Lasergene (DNASTAR) software (Madison, Wisconsin, United
States).
Immunoblotting and immunoprecipitation. For preparation of
protein extracts, 0- to 12-h-old embryos were dechorionated and
homogenized in CHAPS lysis buffer (20 mM Tris [pH 8], 150 mM
NaCl, 10% glycerol, 2 mM EDTA, 10 mM CHAPS) containing
proteinase inhibitors (pepstatin, aprotenin, leupeptin, pefabloc, and
lactacystin). The solution was kept on ice for 10 min and then
centrifuged for 15 min at 4 8C at 13,000 rpm. The supernatant was
transferred into a new reaction tube, and the protein concentration
was measured using the Bradford assay (Bio-Rad, Hercules, Califor-
nia, United States). For SDS-PAGE electrophoresis and Western
blotting, 30 lg of protein was boiled in SDS sample buffer and loaded
onto a discontinuous, horizontal SDS-polyacrylamide gel. Ovaries
were dissected in PBS and directly boiled in SDS-sample buffer. The
separation of the proteins was performed in electrophoresis buffer
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(Schleicher & Schuell, Keene, New Hampshire, United States) and
detected using the following antibodies: rabbit anti-Ago1 (1:250,
Abcam, Cambridge, United Kingdom), rabbit anti-Dcr-1 (1:500,
Abcam), rabbit anti-Loqs (1:2,000; [42]), rabbit anti-Ago2
Cterm
(1:5,000, generated in the Mu ¨ller laboratory against the carboxyl-
terminal peptide CIVPEFMKKNPMYFV), rabbit anti-Ago2 (1:300, gift
of Q. Liu), and rabbit anti-GFP antibody (Molecular Probes). As
secondary antibodies, goat anti-rabbit antibodies conjugated with
HRP were used at 1:10,000 (Jackson) and detected using the BM
Chemiluminescence Blotting Substrate (Roche, Basel, Switzerlan).
For immunoprecipitation, the rabbit anti-Ago2
Cterm was covalently
bound to the coupling gel using AminoLink Plus Immobilization Kit
(Pierce Biotechnology, Rockford, Illinois, United States). Extracts
containing 500 lg of protein were used for each reaction. The extract
was incubated with the covalently bound beads for 1.5 h at 4 8C. The
beads were washed, boiled in SDS-sample buffer, and subjected to
SDS-PAGE and Western blotting.
Scanning electron microscopy. The heads of 2- to 4-day-old adult
female ﬂies were ﬁxed in 30% ethanol. The specimen were
dehydrated with a graded ethanol and acetone series and gradually
transferred into tetra-methyl-silane. After overnight incubation, the
specimen were air-dried, mounted onto double-stick carbon tape,
and sputtered. Scanning electron microscopy imaging was performed
on a LEO scanning electron microscope, and images were processed
with Adobe Photoshop.
Computational analyses of genome data. For Drosophila species,
genomic sequences corresponding to the ago2 locus were retrieved
using the UCSC Genome Browser (http://genome.ucsc.edu) and
analyzed for exon-intron boundaries with the MIT Genscan Web
server (http://genes.mit.edu/GENSCAN.html). For each species, the
predicted exon containing sequences corresponding to the conserved
stretch of D. melanogaster exon 3 was analyzed in detail (Figure S3A).
For D. simulans, the splice-site prediction was veriﬁed by RT-PCR
analysis and sequencing (Y. Guo and M. A. Welte, unpublished data).
For D. mojavensis, the Genscan prediction of the 59 end of exon 3 was
likely incorrect because it would exclude an aa stretch conserved in
other Ago2 proteins. In this case the prediction shown in Figure S3 is
the glutamine-rich open reading frame directly 59 to the conserved
stretch. For the yellow fever mosquito, Aedes aegypti, we found that the
whole genome shotgun sequence AAGE01113413 contains the likely
homolog of ago2 exons 3 and 4. An open reading frame identiﬁed in
this genomic sequence has the capacity to encode a glutamine-rich
region directly 59 to the exon 3 sequences (Figure S3B). For the
African malaria mosquito, Anopheles gambiae, the sequences corre-
sponding to exons 3 and 4 of D. melanogaster ago2 were identiﬁed in
the genomic sequence (using the UCSC Genome Browser). This
region of the genome is apparently expressed as it is also represented
in several spliced EST sequences, including BM597722. These ESTs
were used to determine the 59 extent of the sequence shown in Figure
S3B. For the honeybee, Apis mellifera, the NCBI-predicted protein
XP_395048.2 was used.
Supporting Information
Figure S1. Klar Is Still Functional in ago2
dop1 Embryos
Embryos from wild-type (A), klar
B (B), and ago2
dop1 (C) mothers were
injected with the transcription inhibitor alpha-amanitin to prevent
expression of Halo. In early cycle 14, this global inhibition of
transcription causes a droplet transport defect very similar to
deletion of halo [35]. In klar
B embryos, Klar function is absent, and
the peripheral cytoplasm becomes transparent because lipid droplets
accumulate basally. In both wild-type and ago2
dop1 embryos, droplets
accumulate apically resulting in an opaque periphery.
Found at DOI: 10.1371/journal.pgen.0020134.sg001 (2.0 MB TIF).
Figure S2. Expression of halo Transcripts in Wild-Type and ago2
dop1
Embryos
Full-length halo digoxygenin-labeled antisense in situ probe was used
for in situ hybridization of control (w
1118) embryos (A, C, E, G) and
embryos from ago2
dop1 homozygous mothers (B, D, F, H). (A, B)
Syncytial blastoderm; (C, D) early cycle 14; (E, F) mid-cellularization
stages; and (G, H) late cellularization (fast phase). Note that halo
exhibits strictly zygotic expression, which is downregulated at the end
of cellularization [35]. This expression pattern is largely unimpaired
in ago2
dop1 mutants.
Found at DOI: 10.1371/journal.pgen.0020134.sg002 (1.8 MB TIF).
Figure S3. Cellularization in ago2
51B and ago2
414 Mutant Embryos Is
Unimpaired
Embryos were obtained from Oregon R (wild-type) (A–C), or ago2
dop1
(D–F), ago2
51B (G–I), and ago2
414 (J–L) homozygous mothers, ﬁxed, and
immunolabeled for Arm (red), Nrt (green), and DNA (blue).
Consecutive time points during cellularization are shown from left
to right panels for each genotype. Note that cellularization occurs
normal in ago2
51B and ago2
414 mutant embryos. The kinetics of
membrane formation in ago2
51B and ago2
414 mutant embryos is very
similar to that in the wild-type (unpublished data).
Found at DOI: 10.1371/journal.pgen.0020134.sg003 (6.3 MB TIF).
Figure S4. Distribution of Lipid Droplets in ago2
dop1 and ago2
51B
Mutant Embryos Was Analyzed by Nile Red Staining
Embryos at the extended germband stage were ﬁxed and stained with
the lipid droplet speciﬁc dye Nile Red.
(A) In the wild-type, Nile Red staining is uniformly distributed.
(B) In ago2
dop1 mutant embryos, the outer cell layers are devoid of
staining indicative of failure of lipid droplets to move apically
(compare to Figure 2).
(C) Embryos from klar mutant mothers displays a similar failure of
apical transport.
(D) ago2
51B mutant embryo displays a wild-type distribution of lipid
droplets, indicated by uniform Nile Red staining.
Found at DOI: 10.1371/journal.pgen.0020134.sg004 (6.1 MB TIF).
Figure S5. Amino-Terminal GRRs in Ago2 Proteins from Different
Insects
The protein sequence encoded in ago2 exon 3 of D. melanogaster is
listed at the top. The corresponding region of Ago2 predicted from
genomic sequences are shown for six additional Drosophila species, the
malaria mosquito A. gambiae, the yellow fever mosquito A. aegytpi, and
the honeybee A. mellifera. In each case, a bipartite structure is
apparent: an amino-terminal glutamine-rich region (glutamines
indicated in red and bold) of variable sequence followed by a
conserved stretch at the 39 end of exon 3 (purple). In many instances,
the glutamine-rich regions contain multiple imperfect copies of
distinct repeats (yellow, blue, or green). The 59 extent of the region to
be included was based on EST evidence (A. gambiae), an existing
prediction by NCBI using GNOMON (A. mellifera), or splice-site
predictions using Genscan (Drosophila species except D. mojavensis).
Indented sequence is the portion of the protein employed to
compute glutamine content in Table 3.
Found at DOI: 10.1371/journal.pgen.0020134.sg005 (77 KB DOC).
Figure S6. The ago2
dop1 Mutation Does Not Interfere with the Activity
of the miRNA bantam (ban)
To test for miRNA activity, we employed an eye-based reporter assay
for the function of ban. ban negatively regulates the expression of the
proapoptotic regulator Hid [69]. Expression of ban in the eye using
GMR::Gal4 does not grossly affect eye development (A). Expression of
GMR::hid induces cell death in the retina and thus results in a strongly
reduced eye size (B). This phenotype is only slightly suppressed by the
EP insertion banEP3266 (banEP) alone (C) but strongly suppressed by
overexpression of banEP3266 using GMR::Gal4 (D). To test interference
of ago2
dop1 with ban activity, we performed the same experiment in
ago2dop1 heterozygous (E), ago2dop1 homozygous (F) or ago2
dop1 hemi-
zygous (G) genetic backgrounds. In neither case did we detect a
suppression of ban activity, which should result in a reversion to the
GMR::hid phenotype and produce a strong reduction of the size of the
eye. The increased activity of ban in ago2
dop1 homozygous or
hemizygous ﬂies is explained by two copies of the banEP3266 insertion
present in these animals. We conclude that ago2
dop1 does not inhibit
the activity of ban in regulating Hid expression in this assay.
Interestingly, in an ago2
51B homozygous background (H), activity of
ban seems to be slightly reduced: in the presence of two copies of
ban
EP3266 the size of the eye is considerably smaller as compared to
ago2
51B heterozygotes (I), which contain only one copy of ban
EP3266.
This result suggests that Ago2 might be involved in the activity of ban
to downregulate Hid. The genotypes are indicated above each panel,
respectively. TM6 and MKRS correspond to balancer chromosomes.
Found at DOI: 10.1371/journal.pgen.0020134.sg006 (2.0 MB TIF).
Figure S7. Densitometric Analysis of Independent Western Analyses
Measuring Ago1, Dcr-1, and Loqc Levels in Protein Extracts of
Mutant and Wild-Type Cells
The quantiﬁcation of the Western blots was performed from scanned
images in a linear range using ImageJ from NIH Image. The columns
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detecting Ago1 (n¼3), Dcr-1 (n¼2), and Loqs (n¼3) in wild-type and
ago2 mutants (error bars show standard deviation). All values have
been normalized against the a-tubulin loading control.
Found at DOI: 10.1371/journal.pgen.0020134.sg007 (168 KB DOC).
Accession Numbers
GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession numbers
are whole genome shotgun sequence AAGE01113413 (59568258),
BM597722 (18895825), and protein XP_395048.2 (66517254).
The National Center for Biotechnology Information (NCBI) (http://
www.ncbi.nlm.nih.gov) accession numbers are Argonaute 2 (39683),
Argonaute 1 (36544), Dicer-1 (42693), Dicer-2 (36993), Loquacious
(34751), Klarsicht (38067), Halo (33334), Wingless (34009), Engrailed
(36240), Slam (33890), Armadillo (31151), and DIAP1 (39753).
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